Business Context and Reporting Period
Company: Jean Philippe Fragrances, Inc. (trading as Inter Parfums Inc.)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 1995
Business Overview: The Company is a manufacturer and distributor of fragrances and cosmetics operating in niche markets including domestic/international brand name and licensed fragrances, alternative designer fragrances, and mass market cosmetics. Key brands include Burberrys, Ombre Rose, Jordache, Cutex, and Aziza. Operations are conducted domestically and in approximately 60 countries worldwide through subsidiaries, primarily Inter Parfums, S.A.
Key Financial Metrics (Fiscal Year 1995)
| Metric | 1995 | 1994 |
|---|---|---|
| Net Sales | $93,669,000 | $75,079,000 |
| Gross Margin | $44,966,000 (48%) | $36,043,000 (48%) |
| Net Income | $9,038,000 | $7,275,000 |
| Diluted EPS | $0.87 | $0.70 |
| Working Capital | $41,363,000 | $31,226,000 |
| Cash and Equivalents | $14,204,000 | $5,275,000 |
| Total Assets | $84,001,000 | $69,451,000 |
| Long-Term Debt | $596,000 | $862,000 |
| Bank Loans (Current) | $9,922,000 | $6,681,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 25% to $93.7 million, driven by a 19% increase in domestic operations and a 36% increase in foreign subsidiary sales.
- Product Discontinuance Charge: The Company recorded a nonrecurring pre-tax charge of $2.2 million ($1.3 million after-tax) in Q4 1995 due to the discontinuance of the Cutex lip color line. This resulted from disappointing sales and excessive product returns.
- Gain on Sale of Subsidiary Stock: Net income included a $3.3 million gain from the public offering of 308,000 shares of Inter Parfums, S.A. stock in France. Excluding this gain and the product charge, adjusted net income was $7.1 million.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses rose to 35% of net sales (from 32% in 1994), primarily due to promotional costs for the Cutex line.
- Liquidity: Cash and cash equivalents more than doubled to $14.2 million, supported by operating cash flow of $2.8 million and proceeds from the subsidiary stock offering.
Outlook, Risks, and Management Commentary
- Strategic Focus: Management is refocusing Cutex marketing efforts exclusively on the core nail care business following the discontinuation of the lip color line. A reduction in minimum royalties payable under the Cutex license has been agreed upon with the licensor.
- New Initiatives: The Company relaunched the Aziza hypo-allergenic eye cosmetic line in February 1996 and commenced operations in Brazil (Jean Philippe Brasil) in October 1995.
- Capital Allocation: The Board authorized the repurchase of up to 1,000,000 shares of common stock. As of December 31, 1995, 324,305 shares had been repurchased.
- Real Estate: The Company moved into a new 145,000 square foot distribution center in Dayton, New Jersey, in October 1995, incurring approximately $1.0 million in equipment and improvements.
- Risks: The market is highly competitive. The Company faces risks related to foreign currency fluctuations, reliance on key license agreements (e.g., Burberrys, Jordache), and the ability to meet minimum sales requirements under license agreements.
Key Facts for Investor Verification
- Adjusted Earnings: Verify the sustainability of earnings by excluding the $3.3 million one-time gain on subsidiary stock sales and the $1.3 million after-tax charge for the Cutex lip line.
- Cutex Performance: Monitor the performance of the Cutex nail care line post-discontinuance of the lip color line to ensure it meets the revised royalty and sales expectations.
- Foreign Operations: Assess the contribution of Inter Parfums, S.A. (which accounts for ~38% of sales and ~51% of net income) and the impact of foreign currency exchange rates on future results.
- License Agreements: Review the terms and minimum sales requirements for major licenses (Burberrys, Ombre Rose, Jordache) to ensure compliance and renewal viability.
- Related Party Transactions: Note the short-term loans made to Chairman Jean Madar and CFO Russell Greenberg in early 1996, and the repurchase of shares from officers at prices below market value.